Prostaglandin E2 and cyclic nucleotides during anaphylactic shock in rats

Area of Science:

• Immunology
• Biochemistry
• Pharmacology

Background:

• Anaphylactic shock involves complex biochemical pathways influencing mediator release.
• Prostaglandin E2 (PGE2) and cyclic nucleotides (cAMP, cGMP) are implicated in inflammatory responses.
• Understanding the interplay between these molecules is crucial for managing anaphylaxis.

Purpose of the Study:

• To investigate the relationship between PGE2, cyclic nucleotides (cAMP/cGMP ratio), and plasma histamine during rat anaphylactic shock.
• To elucidate the role of PGE2 in modulating histamine release in anaphylaxis.

Main Methods:

• Anaphylactic shock induced by ovalbumin in sensitized rats.
• Measurement of PGE2, cyclic AMP, cyclic GMP, and plasma histamine levels.
• Administration of dibutyryl cyclic AMP and PGE2 infusion, with and without indomethacin.

Main Results:

• Ovalbumin challenge decreased PGE2 and the cAMP/cGMP ratio, while increasing plasma histamine.
• Dibutyryl cyclic AMP increased PGE2 and inhibited histamine release, an effect blocked by indomethacin.
• PGE2 infusion increased cAMP and the cAMP/cGMP ratio, inhibiting histamine release.

Conclusions:

• Decreased lung tissue PGE2 levels, not the cAMP/cGMP ratio, are the primary cause of elevated plasma histamine in anaphylaxis.
• PGE2 plays a protective role by inhibiting histamine release during anaphylactic shock.
• Therapeutic strategies targeting PGE2 may be beneficial in managing anaphylaxis.